Pseudomigraine with lymphocytic pleocytosis

  • Julio Pascual
  • Natalia Valle

Abstract

Pseudomigraine with temporary neurologic symptoms and lymphocytic pleocytosis is a self-limited syndrome of unknown origin characterized by headache accompanied by transient neurologic symptoms and cerebrospinal fluid lymphocytosis. Patients with this condition are between 15 and 40 years of age. The syndrome is more frequent in men. The clinical picture encompasses one to 12 episodes of changing variable neurologic deficits accompanied by moderate to severe headache and occasional fever. These headaches are described as predominantly throbbing and bilateral with a variable duration (mean, 19 hours). The average duration of the transient neurologic deficit is 5 hours. Sensory (78% episodes), aphasic (66%), and motor (56%) disturbances are the most common. Migraine-like visual symptoms are relatively rare (18% episodes). Patients are asymptomatic between episodes and after the symptomatic period (duration > 3 months). Lymphocytic pleocytosis (10 to 760 cells mm3) and increased cerebrospinal fluid protein are found with negative bacteriologic, viral, fungal, and immunologic studies. Brain computed tomography and magnetic resonance imaging are normal, but an electroencephalogram frequently shows focal slowing over the symptomatic brain area. Single photon emission computed tomography reveals transient focal areas of decreased uptake consistent with the clinical symptoms. It is possible that pseudomigraine with temporary neurologic symptoms and lymphocytic pleocytosis could result from an activation of the immune system secondary to a recent viral infection, which would produce antibodies against neuronal or vascular antigens. This autoimmune attack may induce an aseptic leptomeningeal vasculitis, accounting for the headache and the transient symptoms likely through a spreading depression-like mechanism.

References and Recommended Reading

  1. 1.
    Symonds C: Migrainous variants. Trans Med Soc Lond 1951, 67:237–250.Google Scholar
  2. 2.
    Bartleson JD, Swanson JW, Whisnant JP: A migrainous syndrome with cerebrospinal fluid lymphocytosis. Neurology 1981, 31:1257–1262.PubMedGoogle Scholar
  3. 3.
    Martí-Massó JF, Obeso JA, Carrera N, de la Puente E: Seudomigraña con líquido inflamatorio: un síndrome benigno. Med Clin (Barc) 1984, 83:665–667.Google Scholar
  4. 4.
    Berg MJ, Williams LS: The transient syndrome of headache with neurological deficits and CSF lymphocytosis. Neurology 1995, 45:1648–1654.PubMedGoogle Scholar
  5. 5.
    Gómez-Aranda F, Caladiñas F, Martí-Massó JF, et al.: Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. Brain 1997, 120:1105–1113. The biggest series of this entity, with 50 well-described cases. Clinical picture, complementary data, and pathophysiology are analyzed in detail.PubMedCrossRefGoogle Scholar
  6. 6.
    Brattstrom L, Hindfelt B, Nilsson O: Transient neurological symptoms associated with mononuclear pleocytosis of the cerebrospinal fluid. Acta Neurol Scand 1984, 70:104–110.PubMedCrossRefGoogle Scholar
  7. 7.
    Ferrari MD, Buruma OJ, van Laar-Ramaker M, Dijkmans BC: A migrainous syndrome with pleocytosis. Neurology 1983, 33:813.PubMedGoogle Scholar
  8. 8.
    Richert JR, Potolicchio S Jr, Garagusi VF, et al.: Cytomegalovirus encephalitis associated with episodic neurologic deficit and OKT-8+ pleocytosis. Neurology 1987, 37:149–152.PubMedGoogle Scholar
  9. 9.
    Gekeler F, Holtmannspotter M, Straube A, Klopstock T: Diffusion-weighted magnetic resonance imaging during the aura of pseudomigraine with temporary neurologic symptoms and lymphocytic pleocytosis. Headache 2002, 42:294–296. The first diffusion-weighted study in PMP.PubMedCrossRefGoogle Scholar
  10. 10.
    Caminero AB, Pareja JA, Arpa J, et al.: Migrainous syndrome with CSF pleocytosis: SPECT findings. Headache 1997, 37:511–515.PubMedCrossRefGoogle Scholar
  11. 11.
    Fuentes B, Díez-Tejedor E, Pascual J, et al.: Cerebral blood flow changes in pseudomigraine with pleocytosis analyzed by single photon emission computed tomography: a spreading depression mechanism? Cephalalgia 1998, 18:570–573. Analysis of SPECT in a series of four patients with PMP showing changes compatible with a spreading depression-like mechanism.PubMedCrossRefGoogle Scholar
  12. 12.
    Russell MB, Olesen J: A nosographic analysis of the migraine aura in a general population. Brain 1996, 119:355–361.PubMedCrossRefGoogle Scholar
  13. 13.
    Von Storch TJC, Merrrit HH: The cerebrospinal fluid during and between attacks of migraine headaches. Am J Med Sci 1935, 190:226–231.CrossRefGoogle Scholar
  14. 14.
    Bickerstaff ER: Impairment of consciousness in migraine. Lancet 1961, 2:1057–1059.PubMedCrossRefGoogle Scholar
  15. 15.
    Lee CH, Lance JW: Migraine stupor. Headache 1977, 17:32–38.PubMedCrossRefGoogle Scholar
  16. 16.
    Fishman RA: Cerebrospinal Fluid in Diseases of the Nervous System. Philadelphia: WB Saunders; 1980.Google Scholar
  17. 17.
    Kovàcs K, Bors L, Tòthfalusi L, et al.: Cerebrospinal fluid (CSF) investigations in migraine. Cephalalgia 1989, 9:53–57.PubMedCrossRefGoogle Scholar
  18. 18.
    Marchioni E, Galimberti CA, Soragna D, et al.: Familial hemiplegic migraine with prolonged aura: an uncertain diagnosis in a family. Neurology 1995, 45:33–37.PubMedGoogle Scholar
  19. 19.
    Fitzsimons RB, Wolfenden WH: Migraine coma: meningitic migraine with cerebral oedema associated with a new form of autosomal dominant cerebellar ataxia. Brain 1985, 108:555–577.PubMedCrossRefGoogle Scholar
  20. 20.
    Casteels-van Daele M, Standaert L, Boel M, et al.: Basilar migraine and viral meningitis. Lancet 1981, 1:1366.CrossRefGoogle Scholar
  21. 21.
    Bolay H, Reuter U, Dunn AK, et al.: Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002, 8:136–142. First experimental evidence showing that cortical-spreading depression activates trigeminal afferents that, through a central and peripheral reflex mechanism, cause inflammatory changes in the painsensitive meninges to generate the headache.PubMedCrossRefGoogle Scholar
  22. 22.
    Schraeder PL, Burns RA: Hemiplegic migraine associated with an aseptic meningeal reaction. Arch Neurol 1980, 37:377–379.PubMedGoogle Scholar
  23. 23.
    Constantinescu CS, Chang AP, McCluskey LF: Recurrent migraine and intravenous immune globulin therapy. N Engl J Med 1993, 329:583–584.PubMedCrossRefGoogle Scholar
  24. 24.
    Kappler J, Mohr S, Steinmetz H: Cerebral vasomotor changes in the transient syndrome of headache with neurologic deficit an CSF lymphocytosis (HaDNL). Headache 1997, 37:516–518.PubMedCrossRefGoogle Scholar
  25. 25.
    Serrano-Castro PJ, Amrani Y, Olivares-Romero J: Hemodinámica cerebral en el síndrome de pseudomigraña con pleocitosis: Un estudio con doppler transcraneal. Rev Neurol (Barc) 2000, 31:407–411.Google Scholar

Copyright information

© Current Science Inc 2003

Authors and Affiliations

  • Julio Pascual
    • 1
  • Natalia Valle
    • 1
  1. 1.Service of NeurologyUniversity Hospital Marqués de Valdecilla (UC)SantanderSpain

Personalised recommendations